Fidelity Investments’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $653K | Buy |
70,097
+4,448
| +7% | +$38.7K | ﹤0.01% | 3017 |
|
|
2025
Q4 | $492K | Buy |
65,649
+79
| +0.1% | +$801 | ﹤0.01% | 3090 |
|
|
2025
Q3 | $570K | Buy |
65,570
+3,504
| +6% | +$20.9K | ﹤0.01% | 2985 |
|
|
2025
Q2 | $230K | Buy |
62,066
+54,200
| +689% | +$191K | ﹤0.01% | 3257 |
|
|
2025
Q1 | $25.4K | Buy |
7,866
+5,824
| +285% | +$27.4K | ﹤0.01% | 4134 |
|
|
2024
Q4 | $11.4K | Sell |
2,042
-2,058
| -50% | -$16.1K | ﹤0.01% | 4424 |
|
|
2024
Q3 | $44.3K | Sell |
4,100
-1,012,123
| -100% | -$16.8M | ﹤0.01% | 3830 |
|
|
2024
Q2 | $21.3M | Buy |
1,016,223
+47,341
| +5% | +$1.19M | ﹤0.01% | 1622 |
|
|
2024
Q1 | $30.9M | Buy |
968,882
+965,245
| +26,540% | +$24.6M | ﹤0.01% | 1508 |
|
|
2023
Q4 | $73.7K | Buy |
3,637
+881
| +32% | +$11.6K | ﹤0.01% | 3345 |
|
|
2023
Q3 | $35.1K | Sell |
2,756
-76
| -3% | -$1.27K | ﹤0.01% | 3523 |
|
|
2023
Q2 | $51.2K | Buy |
2,832
+138
| +5% | +$2.54K | ﹤0.01% | 3418 |
|
|
2023
Q1 | $46.3K | Sell |
2,694
-24,208
| -90% | -$471K | ﹤0.01% | 3483 |
|
|
2022
Q4 | $597K | Sell |
26,902
-261,302
| -91% | -$4.04M | ﹤0.01% | 2665 |
|
|
2022
Q3 | $2.32M | Sell |
288,204
-412,248
| -59% | -$3.73M | ﹤0.01% | 2395 |
|
|
2022
Q2 | $4.89M | Sell |
700,452
-390,766
| -36% | -$3.8M | ﹤0.01% | 2244 |
|
|
2022
Q1 | $16.5M | Sell |
1,091,218
-48,957
| -4% | -$769K | ﹤0.01% | 1873 |
|
|
2021
Q4 | $25M | Buy |
1,140,175
+118,202
| +12% | +$2.9M | ﹤0.01% | 1720 |
|
|
2021
Q3 | $27.6M | Sell |
1,021,973
-15,753
| -2% | -$449K | ﹤0.01% | 1681 |
|
|
2021
Q2 | $25M | Sell |
1,037,726
-249,845
| -19% | -$7.65M | ﹤0.01% | 1744 |
|
|
2021
Q1 | $55.9M | Sell |
1,287,571
-306,784
| -19% | -$13.6M | ﹤0.01% | 1348 |
|
|
2020
Q4 | $66.1M | Buy |
+1,594,355
| New | +$65.8M | 0.01% | 1210 |
|
Other funds holding FDMT
RCM
NHAS
BI
VCM
AC
